Immune System, Pain and Analgesia

The Senses: A Comprehensive Reference

Volumn 5, Issue , 2008, Pages 407-427

  Rittner, H L ^a   Machelska, H ^a   Stein, C ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57349114132     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012370880-9.00172-9     Document Type: Chapter

References (130)

1. Abbadie C., Lindia J.A., Cumiskey A.M., Peterson L.B., Mudgett J.S., Bayne E.K., DeMartino J.A., MacIntyre D.E., Forrest M.J. Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7947-7952.
2. Akil H., Owens C., Gutstein H., Taylor L., Curran E., Watson S. Endogenous opioids: overview and current issues. Drug Alcohol Depend. 1998, 51:127-140.
3. Akins P.T., McCleskey E.W. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 1993, 56:759-769.
4. von Andrian U.H., Mackay C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 2000, 343:1020-1034.
5. Arvidsson U., Riedl M., Chakrabarti S., Lee J.H., Nakano A.H., Dado R.J., Loh H.H., Law P.Y., Wessendorf M.W., Elde R. Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J. Neurosci. 1995, 15:3328-3341.
6. Beland B., Fitzgerald M. Mu- and delta-opioid receptors are downregulated in the largest diameter primary sensory neurons during postnatal development in rats. Pain 2001, 90:143-150.
7. Bennet G.J. Animal Models of Neuropathic Pain 1994, 495-510. IASP Press. G.F. Gebhart, D.L. Hammond, T.S. Jensen (Eds.).
8. Bennett D.L., Koltzenburg M., Priestley J.V., Shelton D.L., McMahon S.B. Endogenous nerve growth factor regulates the sensitivity of nociceptors in the adult rat. Eur. J. Neurosci. 1998, 10:1282-1291.
9. Binder W., Mousa S.A., Sitte N., Kaiser M., Stein C., Schafer M. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue. Eur. J. Neurosci. 2004, 20:92-100.
10. Brack A., Labuz D., Schiltz A., Rittner H.L., Machelska H., Schäfer M., Reszka R., Stein C. Tissue monocytes/macrophages in inflammation: hyperalgesia versus opioid-mediated peripheral antinociception. Anesthesiology 2004, 101:204-211.
11. Brack A., Rittner H.L., Machelska H., Beschmann K., Sitte N., Schäfer M., Stein C. Mobilization of opioid-containing polymorphonuclear cells by hematopoetic growth factors and influence on inflammatory pain. Anesthesiology 2004, 100:149-157.
12. Brack A., Rittner H.L., Machelska H., Shaqura M., Mousa S.A., Labuz D., Zöllner C., Schäfer M., Stein C. Control of inflammatory pain by chemokine-mediated recruitment of opioid-containing polymorphonuclear cells. Pain 2004, 112:229-238.
13. Brack A., Rittner H.L., Machelska H., Shaqura M., Mousa S.A., Labuz D., Zöllner C., Schäfer M., Stein C. Endogenous peripheral antinociception in early inflammation is not limited by the number of opioid-containing leukocytes but by opioid receptor expression. Pain 2004, 108:67-75.
14. Braz J., Beaufour C., Coutaux A., Epstein A.L., Cesselin F., Hamon M., Pohl M. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J. Neurosci. 2001, 21:7881-7888.
15. Cabot P.J., Carter L., Gaiddon C., Zhang Q., Schäfer M., Loeffler J.P., Stein C. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J. Clin. Invest. 1997, 100:142-148.
16. Cabot P.J., Carter L., Schäfer M., Stein C. Methionine-enkephalin- and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 2001, 93:207-212.
17. Calixto J.B., Cabrini D.A., Ferreira J., Campos M.M. Kinins in pain and inflammation. Pain 2000, 87:1-5.
18. Chuang H.H., Prescott E.D., Kong H., Shields S., Jordt S.E., Basbaum A.I., Chao M.V., Julius D. Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature 2001, 411:957-962.
19. Cui J.G., Holmin S., Mathiesen T., Meyerson B.A., Linderoth B. Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy. Pain 2000, 88:239-248.
20. Cunha F.Q., Ferreira S.H. Peripheral hyperalgesic cytokines. Adv. Exp. Med. Biol. 2003, 521:22-39.
21. Cunha J.M., Cunha F.Q., Poole S., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br. J. Pharmacol. 2000, 130:1418-1424.
22. Cunha F.Q., Lorenzetti B.B., Poole S., Ferreira S.H. Interleukin-8 as a mediator of sympathetic pain. Br. J. Pharmacol. 1991, 104:765-767.
23. Cunha F.Q., Poole S., Lorenzetti B.B., Ferreira S.H. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br. J. Pharmacol. 1992, 107:660-664.
24. Cunha F.Q., Poole S., Lorenzetti B.B., Veiga F.H., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br. J. Pharmacol. 1999, 126:45-50.
25. Cunha T.M., Verri W.A., Silva J.S., Poole S., Cunha F.Q., Ferreira S.H. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:1755-1760.
26. Czlonkowski A., Stein C., Herz A. Peripheral mechanisms of opioid antinociception in inflammation: involvement of cytokines. Eur. J. Pharmacol. 1993, 242:229-235.
27. Dado R.J., Law P.Y., Loh H.H., Elde R. Immunofluorescent identification of a delta (delta)-opioid receptor on primary afferent nerve terminals. Neuroreport 1993, 5:341-344.
28. Ferreira J., Beirith A., Mori M.A., Araujo R.C., Bader M., Pesquero J.B., Calixto J.B. Reduced nerve injury-induced neuropathic pain in kinin B1 receptor knock-out mice. J. Neurosci. 2005, 25:2405-2412.
29. Ferreira S.H., Lorenzetti B.B., Bristow A.F., Poole S. Interleukin-1 beta as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988, 334:698-700.
30. Ferreira S.H., Lorenzetti B.B., Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 1993, 110:1227-1231.
31. Fukuoka H., Kawatani M., Hisamitsu T., Takeshige C. Cutaneous hyperalgesia induced by peripheral injection of interleukin-1 beta in the rat. Brain Res. 1994, 657:133-140.
32. Gadient R.A., Otten U. Postnatal expression of interleukin-6 (IL-6) and IL-6 receptor (IL-6R) mRNAs in rat sympathetic and sensory ganglia. Brain Res. 1996, 724:41-46.
33. Gazda L.S., Milligan E.D., Hansen M.K., Twining C.M., Poulos N.M., Chacur M., KA O.C., Armstrong C., Maier S.F., Watkins L.R., Myers R.R. Sciatic inflammatory neuritis (SIN): behavioral allodynia is paralleled by peri-sciatic proinflammatory cytokine and superoxide production. J. Peripher. Nerv. Syst. 2001, 6:111-129.
34. + current in rat sensory neurons in vitro. Neurosci. Lett. 1996, 212:83-86.
35. Guan J.S., Xu Z.Z., Gao H., He S.Q., Ma G.Q., Sun T., Wang L.H., Zhang Z.N., Lena I., Kitchen I., Elde R., Zimmer A., He C., Pei G., Bao L., Zhang X. Interaction with vesicle luminal protachykinin regulates surface expression of delta-opioid receptors and opioid analgesia. Cell 2005, 122:619-631.
36. Hargreaves K.M., Dubner R., Costello A.H. Corticotropin releasing factor (CRF) has a peripheral site of action for antinociception. Eur. J. Pharmacol. 1989, 170:275-279.
37. Hermanussen S., Do M., Cabot P.J. Reduction of beta-endorphin-containing immune cells in inflamed paw tissue corresponds with a reduction in immune-derived antinociception: reversible by donor activated lymphocytes. Anesth. Analg. 2004, 98:723-729.
38. Ingram S.L., Williams J.T. Opioid inhibition of Ih via adenylyl cyclase. Neuron 1994, 13:179-186.
39. Jeanjean A.P., Moussaoui S.M., Maloteaux J.M., Laduron P.M. Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P. Neuroscience 1995, 68:151-157.
40. Ji R.R., Zhang Q., Law P.Y., Low H.H., Elde R., Hokfelt T. Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J. Neurosci. 1995, 15:8156-8166.
41. Julius D., Basbaum A.I. Molecular mechanisms of nociception. Nature 2001, 413:203-210.
42. Junger H., Sorkin L.S. Nociceptive and inflammatory effects of subcutaneous TNFalpha. Pain 2000, 85:145-151.
43. Kavelaars A., Ballieux R.E., Heijnen C.J. In vitro beta-adrenergic stimulation of lymphocytes induces the release of immunoreactive beta-endorphin. Endocrinology 1990, 126:3028-3032.
44. Kieffer B.L., Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 2002, 66:285-306.
45. Koltzenburg M., Bennett D.L., Shelton D.L., McMahon S.B. Neutralization of endogenous NGF prevents the sensitization of nociceptors supplying inflamed skin. Eur. J. Neurosci. 1999, 11:1698-1704.
46. Kraus J., Borner C., Giannini E., Hickfang K., Braun H., Mayer P., Hoehe M.R., Ambrosch A., Konig W., Hollt V. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J. Biol. Chem. 2001, 276:43901-43908.
47. Laird J.M., Souslova V., Wood J.N., Cervero F. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J. Neurosci. 2002, 22:8352-8356.
48. Lewin G.R., Rueff A., Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 1994, 6:1903-1912.
49. Li Y., Ji A., Weihe E., Schafer M.K. Cell-specific expression and lipopolysaccharide-induced regulation of tumor necrosis factor alpha (TNFalpha) and TNF receptors in rat dorsal root ganglion. J. Neurosci. 2004, 24:9623-9631.
50. Li M., Shi J., Tang J.R., Chen D., Ai B., Chen J., Wang L.N., Cao F.Y., Li L.L., Lin C.Y., Guan X.M. Effects of complete Freund's adjuvant on immunohistochemical distribution of IL-1beta and IL-1R I in neurons and glia cells of dorsal root ganglion. Acta Pharmacol. Sin. 2005, 26:192-198.
51. Lorenzetti B.B., Veiga F.H., Canetti C.A., Poole S., Cunha F.Q., Ferreira S.H. CINC-1 mediates the sympathetic component of inflammatory mechanical hypersensitivity in rats. Eur. Cytokine Netw. 2002, 13:456-461.
52. Lu C.Y., Chou A.K., Wu C.L., Yang C.H., Chen J.T., Wu P.C., Lin S.H., Muhammad R., Yang L.C. Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats. Gene Ther. 2002, 9:1008-1014.
53. Lyons P.D., Blalock J.E. Pro-opiomelanocortin gene expression and protein processing in rat mononuclear leukocytes. J. Neuroimmunol. 1997, 78:47-56.
54. Machelska H., Brack A., Mousa S.A., Schopohl J.K., Rittner H.L., Schäfer M., Stein C. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain. Br. J. Pharmacol. 2004, 142:772-780.
55. Machelska H., Cabot P.J., Mousa S.A., Zhang Q., Stein C. Pain control in inflammation governed by selectins. Nat. Med. 1998, 4:1425-1428.
56. Machelska H., Mousa S.A., Brack A., Schopohl J.K., Rittner H.L., Schäfer M., Stein C. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J. Neurosci. 2002, 22:5588-5596.
57. Machelska H., Schopohl J.K., Moussa S.A., Schäfer M., Stein C. Different mechanisms of intrinsic pain inhibition in early and late inflammation. J. Neuroimmuno 2003, 14:30-39.
58. Mamet J., Baron A., Lazdunski M., Voilley N. Proinflammatory mediators, stimulators of sensory neuron excitability via the expression of acid-sensing ion channels. J. Neurosci. 2002, 22:10662-10670.
59. Marceau F., Regoli D. Bradykinin receptor ligands: therapeutic perspectives. Nat. Rev. Drug. Discov. 2004, 3:845-852.
60. McLoon L.K., Sandnas A.M., Nockleby K.J., Wirtschafter J.D. Reduction in vesicant-induced cellular inflammation and hyperalgesia by local injection of corticotropin releasing factor in rabbit eyelid. Inflamm. Res. 2002, 51:16-23.
61. McMahon S.B., Bennett D.L., Priestley J.V., Shelton D.L. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat. Med. 1995, 1:774-780.
62. Merskey H., Bogduk N. Pain Terminology. Classification of Chronic Pain. IASP Task Force on Taxonomy 1994, 209-214. IASP Press. H. Merskey, N. Bogduk (Eds.).
63. Mousa S.A., Bopaiah C.P., Stein C., Schäfer M. Involvement of corticotropin-releasing hormone receptor subtypes 1 and 2 in peripheral opioid-mediated inhibition of inflammatory pain. Pain 2003, 106:297-307.
64. Mousa S.A., Machelska H., Schafer M., Stein C. Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain. J. Neuroimmunol. 2000, 108:160-170.
65. Mousa S.A., Schafer M., Mitchell W.M., Hassan A.H., Stein C. Local upregulation of corticotropin-releasing hormone and interleukin-1 receptors in rats with painful hindlimb inflammation. Eur. J. Pharmacol. 1996, 311:221-231.
66. Mousa S.A., Shakibaei M., Sitte N., Schafer M., Stein C. Subcellular pathways of beta-endorphin synthesis, processing, and release from immunocytes in inflammatory pain. Endocrinology 2004, 145:1331-1341. Epub 2003 Nov 1320.
67. Mousa S.A., Zhang Q., Sitte N., Ji R., Stein C. beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J. Neuroimmunol. 2001, 115:71-78.
68. Murphy P.G., Ramer M.S., Borthwick L., Gauldie J., Richardson P.M., Bisby M.A. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur. J. Neurosci. 1999, 11:2243-2253.
69. Obreja O., Biasio W., Andratsch M., Lips K.S., Rathee P.K., Ludwig A., Rose-John S., Kress M. Fast modulation of heat-activated ionic current by proinflammatory interleukin 6 in rat sensory neurons. Brain 2005, 128:1634-1641.
70. Obreja O., Rathee P.K., Lips K.S., Distler C., Kress M. IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C. FASEB J. 2002, 16:1497-1503.
71. Obreja O., Schmelz M., Poole S., Kress M. Interleukin-6 in combination with its soluble IL-6 receptor sensitises rat skin nociceptors to heat, in vivo. Pain 2002, 96:57-62.
72. Oh S.B., Tran P.B., Gillard S.E., Hurley R.W., Hammond D.L., Miller R.J. Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J. Neurosci. 2001, 21:5027-5035.
73. Ohtori S., Takahashi K., Moriya H., Myers R.R. TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord. Spine 2004, 29:1082-1088.
74. Okamoto K., Martin D.P., Schmelzer J.D., Mitsui Y., Low P.A. Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain. Exp. Neurol. 2001, 169:386-391.
75. Opree A., Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-alpha, IL-1 beta, and IL-6 but not IL-8 in the development of heat hyperalgesia: effects on heat-evoked calcitonin gene-related peptide release from rat skin. J. Neurosci. 2000, 20:6289-6293.
76. Pare M., Elde R., Mazurkiewicz J.E., Smith A.M., Rice F.L. The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties. J. Neurosci. 2001, 21:7236-7246.
77. Petruzzelli L., Takami M., Humes H.D. Structure and function of cell adhesion molecules. Am. J. Med. 1999, 106:467-476.
78. Polydefkis M., et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 2002, 58:115-119.
79. Poole S., Cunha F.Q., Selkirk S., Lorenzetti B.B., Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br. J. Pharmacol. 1995, 115:684-688.
80. Porreca F., Lai J., Bian D., Wegert S., Ossipov M.H., Eglen R.M., Kassotakis L., Novakovic S., Rabert D.K., Sangameswaran L., Hunter J.C. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7640-7644.
81. Przewlocki R., Hassan A.H., Lason W., Epplen C., Herz A., Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 1992, 48:491-500.
82. Rittner H.L., Brack A., Machelska H., Mousa S.A., Bauer M., Schäfer M., Stein C. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 2001, 95:500-508.
83. Rittner H.L., Mousa S.A., Labuz D., Beschmann K., Schäfer M., Stein C., Brack A. Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain. J. Leuk. Biol. 2006, 79:1022-1032.
84. Ro L.S., Chen S.T., Tang L.M., Jacobs J.M. Effect of NGF and anti-NGF on neuropathic pain in rats following chronic constriction injury of the sciatic nerve. Pain 1999, 79:265-274.
85. Rueff A., Mendell L.M. Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J. Neurophysiol. 1996, 76:3593-3596.
86. Sacerdote P., Limiroli E., Gaspani L. Experimental evidence for immunomodulatory effects of opioids. Adv. Exp. Med. Biol. 2003, 521:106-116.
87. Sachs D., Cunha F.Q., Poole S., Ferreira S.H. Tumour necrosis factor-alpha, interleukin-1beta and interleukin-8 induce persistent mechanical nociceptor hypersensitivity. Pain 2002, 96:89-97.
88. Safieh-Garabedian B., Poole S., Allchorne A., Winter J., Woolf C.J. Contribution of interleukin-1 beta to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 1995, 115:1265-1275.
89. Sawynok J. Topical and peripherally acting analgesics. Pharmacol. Rev. 2003, 55:1-20.
90. Schäfer M. Cytokines and peripheral analgesia. Adv. Exp. Med. Biol. 2003, 521:40-50.
91. Schäfer M., Carter L., Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:4219-4223.
92. Schäfer M., Mousa S.A., Zhang Q., Carter L., Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:6096-6100.
93. Schäfers M., Brinkhoff J., Neukirchen S., Marziniak M., Sommer C. Combined epineurial therapy with neutralizing antibodies to tumor necrosis factor-alpha and interleukin-1 receptor has an additive effect in reducing neuropathic pain in mice. Neurosci. Lett. 2001, 310:113-116.
94. Schäfers M., Geis C., Svensson C.I., Luo Z.D., Sommer C. Selective increase of tumour necrosis factor-alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve. Eur. J. Neurosci. 2003, 17:791-804.
95. Schäfers M., Lee D.H., Brors D., Yaksh T.L., Sorkin L.S. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-alpha after spinal nerve ligation. J. Neurosci. 2003, 23:3028-3038.
96. Schäfers M., Sorkin L.S., Geis C., Shubayev V.I. Spinal nerve ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia in the rat. Neurosci. 2003, 347:179-182.
97. Schäfers M., Svensson C.I., Sommer C., Sorkin L.S. Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J. Neurosci. 2003, 23:2517-2521.
98. Scholz J., Woolf C.J. Can we conquer pain?. Nat. Neurosci. 2002, 5(Suppl.):1062-1067.
99. Selley D.E., Breivogel C.S., Childers S.R. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol. Pharmacol. 1993, 44:731-741.
100. Sevcik M.A., Ghilardi J.R., Peters C.M., Lindsay T.H., Halvorson K.G., Jonas B.M., Kubota K., Kuskowski M.A., Boustany L., Shelton D.L., Mantyh P.W. Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization. Pain 2005, 115:128-141.
101. Sharp B.M. Opioid receptor expression and intracellular signaling by cells involved in host defense and immunity. Adv. Exp. Med. Biol. 2003, 521:98-105.
102. Shubayev V.I., Myers R.R. Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. J. Neuroimmunol. 2001, 114:48-56.
103. Simonin F., Kieffer B.L. Two faces for an opioid peptide - and more receptors for pain research. Nature 2002, 5:185-186.
104. Smith E.M. Opioid peptides in immune cells. Adv. Exp. Med. Biol. 2003, 521:51-68.
105. Sommer C., Petrausch S., Lindenlaub T., Toyka K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy. Neurosci. Lett. 1999, 270:25-28.
106. Sommer C., Schäfers M., Marziniak M., Toyka K.V. Etanercept reduces hyperalgesia in experimental painful neuropathy. J. Peripher. Nerv. Syst. 2001, 6:67-72.
107. Sorkin L.S., Xiao W.H., Wagner R., Myers R.R. Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997, 81:255-262.
108. Stein C., Gramsch C., Herz A. Intrinsic mechanisms of antinociception in inflammation: local opioid receptors and beta-endorphin. J. Neurosci. 1990, 10:1292-1298.
109. Stein C., Hassan A.H., Lehrberger K., Giefing J., Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 1993, 342:321-324.
110. Stein C., Hassan A.H., Przewlocki R., Gramsch C., Peter K., Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:5935-5939.
111. Stein C., Machelska H., Schafer M. Peripheral analgesic and antiinflammatory effects of opioids. Z. Rheumatol. 2001, 60:416-424.
112. Stein C., Pfluger M., Yassouridis A., Hoelzl J., Lehrberger K., Welte C., Hassan A.H. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J. Clin. Invest. 1996, 98:793-799.
113. Stein C., Schäfer M., Machelska H. Attacking pain at its source: new perspectives on opioids. Nat. Med. 2003, 9:1003-1008.
114. Stucky C.L., Koltzenburg M., Schneider M., Engle M.G., Albers K.M., Davis B.M. Overexpression of nerve growth factor in skin selectively affects the survival and functional properties of nociceptors. J. Neurosci. 1999, 19:8509-8516.
115. Suzuki R., Dickenson A.H. Nerve injury-induced changes in opioid modulation of wide dynamic range dorsal column nuclei neurones. Neuroscience 2002, 111:215-228.
116. Terman G.W., Shavit Y., Lewis J.W., Cannon J.T., Liebeskind J.C. Intrinsic mechanisms of pain inhibition: activation by stress. Science 1984, 226:1270-1277.
117. Vale M.L., Marques J.B., Moreira C.A., Rocha F.A., Ferreira S.H., Poole S., Cunha F.Q., Ribeiro R.A. Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J. Pharmacol. Exp. Ther. 2003, 304:102-108.
118. Vega J.A., Garcia-Suarez O., Hannestad J., Perez-Perez M., Germana A. Neurotrophins and the immune system. J. Anat. 2003, 203:1-19.
119. Verri W.A., Schivo I.R., Cunha T.M., Liew F.Y., Ferreira S.H., Cunha F.Q. Interleukin-18 induces mechanical hypernociception in rats via endothelin acting on ETB receptors in a morphine-sensitive manner. J. Pharmacol. Exp. Ther. 2004, 310:710-717.
120. Wenk H.N., Honda C.N. Immunohistochemical localization of delta opioid receptors in peripheral tissues. J. Comp. Neurol. 1999, 408:567-579.
121. Willer J.C., Dehen H., Cambier J. Stress-induced analgesia in humans: endogenous opioids and naloxone-reversible depression of pain reflexes. Science 1981, 212:689-691.
122. Woolf C.J., Allchorne A., Safieh-Garabedian B., Poole S. Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor alpha. Br. J. Pharmacol. 1997, 121:417-424.
123. Xu Y., Gu Y., Xu G.Y., Wu P., Li G.W., Huang L.Y. Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6204-6209.
124. Xu X.J., Hao J.X., Andell-Jonsson S., Poli V., Bartfai T., Wiesenfeld-Hallin Z. Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 1997, 9:1028-1033.
125. Zhang X., Bao L., Arvidsson U., Elde R., Hokfelt T. Localization and regulation of the delta-opioid receptor in dorsal root ganglia and spinal cord of the rat and monkey: evidence for association with the membrane of large dense-core vesicles. Neuroscience 1998, 82:1225-1242.
126. Zhang N., Inan S., Cowan A., Sun R., Wang J.M., Rogers T.J., Caterina M., Oppenheim J.J. A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4536-4541.
127. Zöllner C., Shaqura M.A., Bopaiah C.P., Mousa S.A., Stein C., Schäfer M. Painful inflammation induced increase in μ opioid receptor binding and G-protein coupling in primary afferent neurons. Mol. Pharm. 2003, 64:202-210.
128. Zwick M., Molliver D.C., Lindsay J., Fairbanks C.A., Sengoku T., Albers K.M., Davis B.M. Transgenic mice possessing increased numbers of nociceptors do not exhibit increased behavioral sensitivity in models of inflammatory and neuropathic pain. Pain 2003, 106:491-500.
129. Machelska H., Stein C. Immune mechanisms in pain control. Anesth. Analg. 2002, 95:1002-1008.
130. - International Association for the Study of Pain. http://www.iasp.pain.org.